Geode Capital Management, LLC Sonoma Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 86,644 shares of SNOA stock, worth $248,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,644
Previous 35,780
142.16%
Holding current value
$248,668
Previous $6,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SNOA
# of Institutions
15Shares Held
434KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il195KShares$560,1000.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$129,9960.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$69,7840.0% of portfolio
-
Hrt Financial LP New York, NY21.5KShares$61,7590.0% of portfolio
-
Xtx Topco LTD London, X019.8KShares$56,9230.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $8.9M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...